Wednesday, July 8, 2026

biotech · Plaque Psoriasis · Rheumatoid Arthritis · CANF

Can Fite Biopharma

Can Fite Biopharma is a biotech organization headquartered in RAMAT GAN, L3, USA. It trades on NYSE under ticker CANF. Primary therapeutic focus areas include Plaque Psoriasis, Rheumatoid Arthritis, Hepatocellular Carcin

10 Bareket Street, פ"ת, IL, RAMAT GAN, L3, USA HQ
9 Employees
Public company Type
CANF · NYSE Ticker
Company details
Status
Public
HQ
10 Bareket Street, פ"ת, IL, RAMAT GAN, L3, USA
Employees
9
Programs
20
Drugs
4
Patents
23
Clinical program

CF101 1 mg

Phase 3 · small molecule · Rheumatoid Arthritis

CF101 1 mg for Rheumatoid Arthritis is a Phase 3 program (small_molecule) at Can-Fite BioPharma with 1 ClinicalTrials.gov record(s).

← All Can-Fite BioPharma projects Phase 3 small molecule terminated

Internal code CF101-301RA

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Can-Fite BioPharma
Phase
Phase 3
Modality
small_molecule
Indication
Rheumatoid Arthritis
Status
terminated
Trials
1

Clinical trials